Despite the enormous progress in the prevention and control of infectious diseases during the past few decades, infectious diseases have become a commonality for the biomedical community. The World Health Organization (WHO) estimates that infectious diseases contribute 25% to the total annual deaths that occur worldwide, and the proportion is even higher in the developing countries.[@bib0040] The extent of the global burden of infectious diseases depends on the already established incidences and prevalence of known infections together with the constant, but uneven, flow of emerging and re-emerging infections. Infectious diseases have remained among the leading causes of death universally primarily because of the emergence of new infectious diseases, re-emergence of old infectious diseases, and persistence of intractable infectious diseases. Emerging infectious diseases (EIDs) are outbreaks of previously unknown diseases or known diseases, whose incidence in humans have significantly increased in the past two decades or are threatening to increase in the near future in frequency--geographic range, or both.[@bib0045] Emergence may be due to the spread of a new agent, recognition of an infection that has been present in the population, but has gone undetected, or the realization that an established disease has an infectious origin. The acquired immunodeficiency syndrome (AIDS) pandemic, though now a fundamental matrix disease, is a prototype of a truly EID, whose impact on public health had not been previously experienced prior to 1981.

Re-emerging or resurging diseases are known diseases that have reappeared after a significant decline or a period of quiescence in incidence either in a more virulent form or a different epidemiological setting.[@bib0045] The influenza A pandemics of 1918, 1957, and 1968, occurrences of West Nile virus in western hemisphere, and dengue in Brazil are some of the examples of re-emerging diseases in a different epidemiological location.[@bib0050]

With recognition of an immune deficiency syndrome in the early 1980s that was subsequently documented to be caused by human immunodeficiency virus (HIV), the world has witnessed one emerging infection after another. The extent of the huge global impact that some of these emerging infections can have is evident from the fact that since the start of the AIDS pandemic, approximately 40 million people worldwide have become HIV infected (developing world alone accounting for 90% of the new cases), resulting in 12 million deaths because of AIDS or AIDS-related diseases.[@bib0055] In an analysis of EIDs between 1940 and 2004, it has been observed that a majority (about 60--75%) are caused by *zoonotic* pathogens, and vector borne diseases are responsible for 23% of them.[@bib0045] Zoonotic diseases assume a greater public health importance in a country like India where along with an abundance of vectors, approximately 80% population lives in close contact with domesticated animals and poultry. Laced with successes and failures, India has had its share of emerging infections like those caused by *Vibrio cholerae* O139, *Yersinia pestis*, Group B Rota virus, HIV, Nipah virus, chikungunya virus, Chandipura encephalitis virus, and influenza viruses. The interplay of the dynamic interaction between the classical epidemiological triad of host, agent, and environment has contributed to the same.

Emerging infections are mostly caused by pathogens already present in the environment, brought out of obscurity or given a selective advantage to infect new host populations. An expert committee from Center for Disease Control (CDC) identified six major factors that contribute to disease emergence and re-emergence:1.Changes in human demographics and behavior,2.Advances in technology and changes in industry practices,3.Economic development and changes in land-use patterns,4.Dramatic increases in volume and speed of international travel and commerce -- movement not only of people but of animals, foodstuffs, and other commodities,5.Microbial adaptation and change, and6.Breakdown of public health capacity required for infectious diseases at the local, state, national, and global levels.[@bib0060]

The current spate of attention belies the fact that emerging infections are a recent phenomenon and suggest that they have always played a major role in human history. In addition to the AIDS, severe acute respiratory syndrome (SARS), and influenza pandemics that have had severe global impact, a continual evolution with consequent impact of a wide range of emerging and re-emerging infectious diseases is evident:•Some EIDs such as Ebola virus hemorrhagic fever, Nipah virus encephalitis, and Hanta virus hemorrhagic fever with renal and pulmonary syndrome have been highly virulent but restricted in their spread and hence have been more medical curiosities than global public health threats.•Infections such as drug-resistant malaria have affected large number of people, but due to the demographic distribution, they are more of concern in a geographically restricted region rather than being a global public health threat.•Hepatitis C virus, first identified in 1989, is now the most common cause of transfusion hepatitis globally, and has a tremendous global impact in terms of chronicity and risk for developing liver cirrhosis and/or liver cancer.•Recent re-emerging infections such as dengue and West Nile fever in new epidemiological settings are a cause of concern in the United States because of the widely dispersed mosquito vectors.•Emerging diseases of bacterial origin such as Legionnaire\'s disease, *Escherichia coli* O157:H7, *Borrelia burgdorferi*, *V. cholerae* O139 have now become a common cause of concern.•Re-emergence of infections is often linked to epidemiological changes. Cholera outbreaks can emerge afresh in places with poor water supply and deteriorating sanitation system. Likewise re-emergence of diptheria in certain places such as the Russian Federation in 1994 was linked to a dramatic decline in immunization programs. Rift valley fever re-emerged in Kenya and Somalia in 1997---1998 because of climatic change, which lead to increase in vector population. Continuing threat of emergence of resistant strains of a number of important microbes, including pneumococci, enterococci, staphylococci, *Plasmodium falciparum*, *Mycobacterium tuberculosis*, and HIV, due to the inappropriate use of antimicrobials on a wider scale than ever before has the potential to seriously affect the public health throughout the world.•A number of chronic and neoplastic diseases are now associated with microbial infections; the most significant among them being association of persistent *Chlamydia pneumonia* infection with pathogenesis of coronary artery disease and gastric carcinoma, hepatocellular carcinoma, and carcinoma cervix etiologically related to *Helicobacter pylori*, hepatitis B virus, and human papilloma virus, respectively.

Typhus is rarely diagnosed as a cause of pyrexia of intermediate duration, and the public health importance of this disease is underestimated due to lack of diagnostic facilities and a low index of suspicion among health care workers due to the non-specific nature of the clinical signs and symptoms. A recent Indian study, which used PCR as a rapid and specific test for quick diagnosis of scrub typhus, reported that scrub typhus accounts for nearly 20% of all cases of pyrexia of intermediate duration in endemic areas.[@bib0065] A recent report from Delhi emphasizes the importance to have a high index of suspicion for rickettsial diseases in cases of fever occurring in the monsoon and post-monsoon season in Delhi and adjoining areas, as rickettsial diseases may become a serious public health problem in the absence of diagnosis or misdiagnosis.[@bib0070]

The perpetual nature of the emergence of infectious diseases poses a volatile ever-changing challenge, and there is no doubt that new and previously unrecognized infections will continue to infect globally. It may be possible that some of these newly emerging infections could be more a function of increased detection than actual emergence in human population; the striking example of which is *Legionella* bacterium responsible for the high-mortality pneumonia known as Legionnaires' disease. Today, the contribution of genomics and proteomics in the discovery of new infectious diseases and in the better understanding of the pathogenesis of the existing ones has substantially improved disease surveillance, and helps elucidate host susceptibility factors and host responses to treatment of infections. In response to continuous emergence and re-emergence of infectious diseases, various national and international organizations such as WHO, CDC, the National Institute of Health (NIH), Department of Defense, and the Food and Drug Administration (FDA) have collaborated to develop strategic plans to combat the menace. A five pronged strategy comprising epidemic preparedness, appropriate health infrastructure, effective risk communication, research, and political commitment for partnership building has been suggested for countries of the South-East Asia region (WHO South-East Asia Regional Office, 2005).[@bib0055] With global eradication of the devastating diseases such as small pox in 1980 and epizootic morbillivirus disease, rinderpest, in 2011, with dracunculiasis and polio close to eradication and measles on the path to eradication, it is now becoming possible to optimistically consider eradication as an ultimate means of controlling some of the emerging and re-emerging infectious diseases.
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